Pricing Log in Create free account

Abeona Therapeutics Inc. (ABEO) vs Rocket Pharmaceuticals, Inc. (RCKT)

Abeona Therapeutics Inc. and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Rocket Pharmaceuticals, Inc. are of similar size ($265.9M and $259.1M). Rocket Pharmaceuticals, Inc. has the higher net margin (0.00% vs −242.6%) and the lower return on invested capital (−114.7% vs 0.00%). Across the 14 metrics below, Rocket Pharmaceuticals, Inc. leads on 10 and Abeona Therapeutics Inc. on 4.

Valuation

Metric ABEO RCKT Biotechnology median
P/E n/m n/m 8.50
P/S 9.68 n/m 9.71
P/B 1.96 0.67 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.07 0.64
EV/Sales 4.60 n/m 9.21
Earnings yield (26.59%) (7.34%) (33.15%)
Free cash flow yield (32.48%) (69.93%) (25.50%)

Profitability

Metric ABEO RCKT Biotechnology median
Gross margin 66.03% 0.00% 65.16%
Operating margin (322.59%) 0.00% 0.00%
Net margin (242.62%) 0.00% 0.00%
Free cash flow margin (314.53%) 0.00% 0.00%
Return on equity (43.13%) (4.77%) (56.36%)
Return on assets (29.54%) (4.09%) (48.04%)
Return on invested capital 0.00% (114.71%) 0.00%

Growth

Metric ABEO RCKT Biotechnology median
Revenue growth (TTM) 427.47% — 6.02%
EPS growth (last fiscal year) 165.16% 26.37% 30.26%
Revenue growth, 5-year CAGR 14.19% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABEO RCKT Biotechnology median
Debt to equity 0.12 0.05 0.00
Current ratio 6.63 9.24 4.72
Net debt to EBITDA 2.00 0.77 0.96

Dividend

Metric ABEO RCKT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABEO RCKT Biotechnology median
Market cap 265.90m 259.07m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack